Step-specific investigation of SNARE-mediated membrane fusion by Kim, Sunae
Graduate Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2013
Step-specific investigation of SNARE-mediated
membrane fusion
Sunae Kim
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/etd
Part of the Biophysics Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Kim, Sunae, "Step-specific investigation of SNARE-mediated membrane fusion" (2013). Graduate Theses and Dissertations. 13344.
https://lib.dr.iastate.edu/etd/13344
 
 
 
Step-specific investigation of SNARE-mediated membrane 
fusion 
by 
Sun-Ae Kim 
 
 
A dissertation submitted to graduate faculty 
in partial fulfillment of the requirements for the degree of 
DOCTOR OF PHILOSOPHY 
 
Major: Biophysics 
Program of Study Committee: 
Yeon-Kyun Shin, Major Professor 
Alan Myers 
Mark Hargrove 
Edward Yu 
Richard Honzatko 
 
Iowa State University 
Ames, Iowa 
2013 
Copyright ©Sun-Ae Kim, 2013. All rights reserved. 
  
ii 
 
TABLE OF CONTENTS 
 
ABSTRACT……………………………………………………………………...………iv 
 
CHAPTER 1: GENERAL INTRODUCTION………………………………..………01 
Introduction……………………………………………………………………………..01 
Dissertation Organization……………………………………...………………………08 
References……………………………………………………………………………….08 
Figures and Captions……………………………………………………...……………13 
 
CHAPTER 2: FUSION STEP-SPECIFIC STIMULATION AND INHIBITION 
BY CHOLESTEROL IN SNARE-MEDIATED MEMBRANE FUSION…......……19 
  
Abstract………………………………………………………………………………….19 
Introduction…..…………………………………………………………………………20 
Results…………………………………………………………………………………...22 
Discussion……………………………………………………………………………….27 
Methods ……………………………………………………………….…….…………..30 
References……………………………………………………………………………….35 
Figures and Captions…………………………………………………………………...39 
 
CHAPTER 3: CHOLESTEROL INCREASES DOCKING, LIPID MIXING, AND 
CONTENT RELEASE ON SNARE-MEDIATED MEMBRANE FUSION………..44 
Abstract ……….………………………………………………………………………...44 
Introduction………………………..……………………………………………………45 
Results………………………………………...…………………………………………47 
Discussion……………………………………………………………………………….50 
Methods………………………………………………………………………………….53 
iii 
 
References………………………………………………………….……………………56 
Figures and Captions………………………………………………….………………..58 
 
CHAPTER 4: α-SYNUCLEIN INHIBITS SNARE-DEPENDENT MEMBRANE 
FUSION IN THE DOCKING STEP…………………………………….….…………66 
Abstract……………………………………………………………….….……………...66 
Introduction………………………………………………………….….………………67 
Results…………………………………………………………………..……………….68 
Discussion……………………………………………………………….………………72 
Methods…………………………………………………………………….……………75 
References………………………………………………………………………….……80 
Figures and Captions…………………………………………………...………………93 
 
CHAPTER 5: GENERAL CONCLUSION……………………………………..……99 
 
ACKNOWLEDGMENTS…..……………………………………………………...…101 
  
iv 
 
ABSTRACT 
  Cholesterol is a major component of biological membranes and is known to affect 
vesicle fusion. However, the mechanism by which cholesterol modulates SNARE-
dependent intracellular fusion is not well understood. First, using the fluorescence assay 
and employing dye-labeled SNAREs and the fluorescent lipids on yeast post golgi 
trafficking SNARE-mediated model membrane fusion, we dissected cholesterol effects 
on individual fusion steps including SNARE complex formation, hemifusion, pore 
formation, and pore dilation. At physiological high concentrations, cholesterol stimulated 
hemifusion as much as 30-fold, but its stimulatory effect diminished to 10- and 3-folds 
for subsequent pore formation and pore expansion at 40 mole%, respectively. Therefore, 
the results show that cholesterol serves as a strong stimulator for hemifusion but acts as 
mild stimulators for pore opening and expansion. Strong stimulation of hemifusion and 
mild stimulation of pore formation are consistent with the fusion model based on the 
intrinsic negative curvature of cholesterol. However, even a milder effect of cholesterol 
on pore expansion is contradictory to such a simple curvature-based prediction. Thus, we 
speculate that cholesterol also affects the conformation of the transmembrane domains of 
SNAREs, which modulates the fusion kinetics. Furthermore, we investigated the effect of 
cholesterol in the specific steps of fusion: docking, lipid mixing, spontaneous fusion, and 
Ca
2+
-triggered fusion using single vesicular study. Cholesterol enhances the kinetics of 
all these steps. Cholesterol on both sides of the vesicles is required for content mixing. In 
addition, cholesterol helped Syntaxins assemble to form higher oligomers meanwhile the 
higher oligomer ratio of Vamp was not affected by cholesterol content.  
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α-Synuclein (α-Syn), a major component of Lewy bodies that are considered as a 
hallmark of Parkinson’s disease (PD), has been implicated in neuroexocytosis. 
Overexpression of α-Syn decreases the neurotransmitter release. However, the 
mechanism by which α-Syn inhibits the neurotransmitter release is still unclear. Here, we 
investigated the effect of α-Syn on SNARE assembly and SNARE-dependent liposome 
fusion using fluorescence methods. The results show that α-Syn inhibits bulk lipid mixing. 
Furthermore, mutants linked to familial PD A30P, A53T, and E46Kare less effective than, 
similar to, more than the wild-type in fusion-inhibition, respectively, correlating well 
with the rank order of their individual membrane affinities. A negatively-charged lipid 
that strongly favors α-Syn's membrane binding is also required for the fusion-inhibiting 
function. Finally, the single-vesicle fusion assay reveals that α-Syn specifically inhibits 
vesicle docking, without interfering with lipid mixing and pore opening. Thus, α-Syn 
may inhibit SNARE-dependent vesicle docking through membrane binding.
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CHAPTER 1: GENERAL INTRODUCTION 
Introduction 
SNAREs 
Various living systems have evolved to manage cargo entry through the merging 
of two membranes into one. For example, newly synthesized proteins and lipids must be 
transferred to their destinations by fusing cargo vesicles to plasma membrane and 
neurotransmitters must be released by fusion of synaptic vesicles to presynpatic 
membrane [1]. Most of those intercellular fusions are mediated by membrane protein sets, 
referred to as SNAREs (soluble N-ethylmaleimide Sensitive Factor Attachment Protein 
Receptors) [2-5]. These proteins are known to be the basic machinery for membrane 
fusion [6, 7]. SNARE proteins contain one or two SNARE motifs (Figure 1A) that are 
60-70 amino acids long and 4 sets of SNARE motifs form a coiled coil (Figure1B) 
making heptad repeats in which hydrophobic residues are close to each other periodically 
along the a and d positions (Figure1C, blue box). There are two uniquely conserved 
residues, Q and R, in those layers that are not hydrophobic. These two residues are Q or 
R.  SNAREs are divided according to these residues into two groups; Q-SNARE and R-
SNARE (Figure1C. Red and Green) and, conventionally, Q or R in the SNARE motif 
complex is called the 0th layer [8]. Q-SNARE is also called T-SNARE and R-SNARE V-
SNARE using the initials of target and vesicle in which the SNAREs resided [9].  
Two of the first known and most widely studied SNARE-mediated membrane 
fusion systems are neurotransmitter release and golgi trafficking in Yeast. The neuronal 
SNAREs were discovered in 1998. Three SNARE protein sets are Syx1A, Vamp2 and 
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SNAP25 (Figure1A). Syx1A and Vamp2 have transmembrane domains. Here, Syx1A 
and SNAP25 are T or Q SNAREs. They constitute a binary complex with SNAP25 that 
confers 2 SNARE motifs, and reside in the plasma membrane of a presynaptic site. 
SNAP25 has 4 cysteines which form palmitoylation sites, but it is known to be unrelated 
to membrane fusion so, in our system for simplicity we used a cystein-free version of 
SNAP25. Vamp 2 is also called Synaptobrevin and resides in the vesicles. The crystal 
structure of the SNARE complex was revealed in 1998 (Figure1B)[10] and also 
examined by site-directed spin labeling EPR [11].  
SNAREs create a complex from N-terminal to C-terminal known as Zippering 
model [12]. During this process energy of 18-35 kT per SNARE complex is released [13-
16]. Once the S     core complex is formed, it is very stable in that it is SDS-resistant 
under      [17]. In yeast trafficking from Golgi to plasma membrane, Sso1p, Sec9, and 
Snc2 are the corresponding SNAREs. Each of them is analogous to SNAREs syx1A, 
SNAP25, and Vamp2 in Neuronal system, respectively. 
Fusion pathways and membrane fusion models 
SNARE-mediated membrane fusions occur through a series of several steps: 
Vesicles undergo tethering, docking/priming, hemifusion, fusion pore opening, and full 
collapse (Figure2). With the help of Rab proteins, vesicles are positioned near the plasma 
membrane and then SNARE proteins begin to form a SNARE complex, a process called 
docking. Next the two membranes become closer and even the outer layers of two 
opposing layers are merged without fusion of distal layers. This step is called Hemifusion. 
Next even the inner layers of two membranes are fused allowing the passage of aqueous 
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contents. To make the fusion of two opposing membranes occur, rearrangement of 
bilayers are mandatory and includes bending of two bilayers in the middle of the step. 
Two possible lipidic fusion intermediates have been proposed. One is an inverted micelle 
that is not considered adaptable to wide range of membrane types. The other is the stalk 
model.  After it was proposed, it was modified by Siegel, et. Al., and included an 
explanation of hydrophobic void space and geometry. With respect to biological 
membranes, the high energy due to hydrophobic void is relieved by combination of 
various lipids. Proteins involving fusion will also affect the geometry of a fusion site.  
For a stalk to reach full fusion, two theoretical models have been proposed. One is the 
TMC, and the other is the hemifusion model (Figure3A and B). It is believed that the 
fusion stalk is expanded in to a fusion pore [18]. In the protein-free membrane fusion, the 
fusion pathway goes through stalk formation and hemifusion exhibiting behavior of 
lipidic fusion model [19, 20]. Hemifusion intermediates have also been experimentally 
proven to exist [21-25]. In the gap-junction model, the fusion site is mostly occupied by 
proteins. It was also found that fusion pores were lined by Syntaxins from the mutation 
study (Figure 3C) [26]. The proteinaceous model and hemifusion model seemed 
contradictory between in that either proteins or lipid molecules are occupying the fusion 
site. In a 2008 study, using yeast homologs of neuronal SNARE proteins, Cy3 was 
attached on the sso1p N-terminus and other Cy5 dye was attached to snc2p, and it was 
found that the kinetics of Cy3 increased and that of self-quenching of Cy5 was the same, 
indicating that the GAP junction happens sequentially with hemifusion [27]. Another 
study on curvature elasticity of fusion pores also revealed that the lipidic fusion pore 
follows after the initial protein fusion pore [28].  
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Constitutive vs regulated fusion 
Some of the interacting proteins of SNAREs in mammalian neurons are not 
expressed in yeast vacuole system. Many types of fusions occur spontaneously and are 
called constitutive secretions. The difference between regulated fusion and constitutive 
fusion not only resides in the difference between SNAREs themselves and regulator 
proteins, but also depends on whether the fusion occurs upon a signal [29, 30]. The 
energetic change from regulated SNARE-mediated fusion into constitutive one in 
neurons is shown below in Figure 4, regulatory proteins such as complexin and 
Synaptotagmin with Ca
2+
 are necessary. Regulations can occur through the control of 
Ca
2+
 sensitivity, fusion kinetics, fusion pore dilation and other fusion-specific steps. In 
the first step, zippering of the N-terminal of the SNARE complex confers 35kT of energy 
[13] to overcome the priming barrier by stabilizing the SNARE pin, and these SNARE 
pins became stable when the distance between two bilayers is within 8nm [13]. However, 
the exact role of regulatory proteins is still not completely revealed in the later step or 
even in the priming reaction. 
Vesicle pools 
A readily-releasable pool (RRP) of ready-to-go vesicles is on the active site of the 
presynaptic plasma membrane (Figure5 Left). Also rapid recycling followed to maintain 
the releasable vesicle pool.  RRP is part of the recycling pool of synaptic vesicles. In 
addition to these active vesicles, many vesicle clusters contain an inactive “ esting Pool” 
[31]. However, release occurs only in RRP vesicles. RRP is defined operationally as the 
amount of release triggered by application of hypertonic sucrose, which induces Ca
2+
-
5 
 
independent exocytosis. Also RRP is also characterized as kinetics of 20-30ms at 20uM 
Ca
2+
; on the other hand slowly releasable pool(SRP) has a time constant of ~200ms at  
20uM Ca
2+ 
(Figure5 Left). There are three types of neurotransmitter releases that depend 
on the action potential dependency and response time. Evoked synchronous release 
occurs with a time constant of 6–7 ms after the action potential (Figure5 Right (a)). 
Evoked asynchronous release is a slow component with a time constant of 200–300ms 
(Figure5 Right (b)). These evoked fusions are detected as EPSC (Excitatory Post 
Synaptic Current). On the other hand, spontaneous release is independent of action 
potential but still related to Calcium ions. This miniature EPSC (mEPSC) (Figure5 Right 
(c)) comes from single vesicles induced by resting Ca
2+
 concentration, other stochastic 
Ca
2+
-channel opening or Ca2+ sparks via Ca2+-influx from internal Ca2+-stores [32]. 
Regulatory proteins: Complexin and Synaptotagmin 
Complexin(Cpx)  
Among several regulatory proteins including Synaptotagmin, Munc18, and Cpx, 
Cpx is the most puzzling molecule because distinct domains of Cpx seem to have 
different functions.  Cpx is a small (1-134aa 15KD) and soluble protein. Cpx, also called 
Synaphin was identified in 1995 by three different research groups [33-35]. It is highly 
charged (48% of the total residues) and especially rich in glutamic acid and lysine 
residues (accounting for more than 1/3 of the total residues)[33]. Cpx has four isoforms 
(I-IV) [36]. CpxI and CpxII are very similar (86% identical in a rat) and they also have 
overlapping roles even though CpxI is exclusively expressed in the central nervous 
system while CpxII is present in non-neuronal cells. As for two Cpx and Synaptotagmin1 
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(Syt1), the Syt1/CplxI/CplxII TKO mutant rats died as soon as they were born, indicating 
that the functions of Cpx and Syt are crucial.  The crystal structure of Cpx(amino acid 26-
83) was revealed in 2002 showing that Cpx binds to the SNARE complex in an 
antiparallel way [37]. The Kd value between Cpx and the SNARE complex was found to 
be 10nM [38] and other research shows that the Ka alue between Cpx and the SNARE 
complex is 7.0x10
7
 M
-1
s
-1
(kd=143nM) [39]. The binding occurs very fast and very tightly. 
Cpx binds to the groove of Syntaxin-1 and Vamp2 (synaptobrevin2). In the crystal 
structure, Cpx (aa26-83) binds to the SNARE helical bundle up to layer +3 or +4 which is 
considered sufficient to stabilize the SNARE complex [37]. 
Synaptotagmin 
Neurotransmitter release occurs upon an action potential followed by Calcium 
influx. Synaptotagmin 1 is known as a calcium sensor for neurotransmitter release [40, 
41]. Along with SNAREs, Synaptotagmin 1 directly affects fusion kinetics while other 
regulatory proteins only affect the amount of fusion [42], indicating that synaptotagmin is 
involved in the last step of release.  Synaptotagmin 1 is one of 17 superfamilies [43-45] 
and is composed of a short N-terminal region inside the vesicle, TMD, polybasic 
juxtamembrane region and tandem C2 domains. The C2A and C2B domains catch 2 and 
3 calcium ions respectively [46, 47]. By binding these calcium ions, synaptotamin 
conformation changes and inserts into the plasma membrane with a wedge-like shape, 
inducing more curvature on the plasma membrane resulting in fusion [48]. 
Synaptotagmin also has Ca
2+
-independent role. It directly binds to SNAREs to enhance 
docking and also interacts with anionic phopholipids such as PS and PIP2 [49]. One of 
the mechanisms proposed is that synaptotamin binds to a binary T -SNARE before 
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Vamp2 is interacting with them. When Vamp2 starts to zip with binary T, synaptotagmin 
detaches from the complex and later after Vamp2 creates a complex and calcium is 
injected, synaptotagmin rebinds to this ternary complex [50]. 
Single molecular FRET experimental setup: tethered vesicle system and planar 
supported bilayer system 
Tethered vesicle system 
Immobilization of vesicles onto a quartz slide surface requires several steps. The 
reason for the immobilization is not only to attach specific molecules but also to 
minimize non-specific binding. The affinity between biotin and neutravidin is very high. 
The treatment steps are shown below and in Figure 6. 
Step0. Cleaning the slides 
Step1. Quartz Surface activation: SiOH -> SiO2  
Step2. Silanization 
Step3. PEGylation(BiotinPEG) 
Step4. Neutravidin loading 
Step5. Biotinyl PE contained Vesicles loading 
Planar supported bilayer system 
Vesicles containing PEG moiety were directly deposited onto clean hydrophilic 
quartz surface. 
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Dissertation Organization 
Chapter one provides some general background on SNARE-mediated membrane 
fusion: introduction of SNAREs and mechanism of membrane fusion, SNARE regulators, 
and research method. Chapter two describes the fusion step specific influence of 
cholesterol on yeast SNARE mediated membrane fusion and it has been published in the 
Biophysical Journal in 2009. Chapter three explains that how cholesterol increases 
docking and content release on Neuronal SNARE-Mediated Membrane Fusion. In 
Chapter 4, alpha-synuclein's effect on membrane fusion is discussed. All of the above 
research is summarized in Chapter 5. 
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Figures and Captions  
 
Figure1. (A) The neuronal SNARE set is shown. Colored area is SNARE motif [51]. (B) Crystal 
sturucture of the SNARE complex is presented with numbers indicating Ionic layers (C) Ionic layers 
with amino acids in SNAREs [10]. 
 
 
  
 
 
 
 
A 
C 
B 
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Figure 2. Pathways for SNARE-mediated membrane fusion model [52] (a) With the help of tethering 
proteins, vesicles are positioned near to the target membrane. (b) From loosely bound state, two 
membranes are closely located by zippering of SNREs. (c) With further zippering, very close two 
membranes spontaneously make outer layers fuse, called hemifusion and this is a hallmark of the 
lipidic fusion model or hemifusion model. Fusion is initiated by the Stalk formation (d) the 
energetically unfavorable void in the hemifusion diaphragm will induce the contact of inner layers. (e) 
Inner layers also fuse and the aqueous contents are released into the target membrane. (f) Pore 
dilates and two different compartments become identical.  
15 
 
 
 
Figure3. Two Models on membrane fusion [16] (A) Proteinaceous fusion model. Green shape 
indicates transmembrane domain of SNAREs. (B) Lipidic fusion model (C) Proteinaceous fusion 
pore is lined by Syntaxins. 
  
A B 
C 
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Figure4. Energy diagram [53] (A) Regulated fusion. RRP (Readily Releasable Pool) is positioned in 
primed state. Calcium can lower the fusion barrier. (B) Constitutive fusion has relatively flat 
landscape. In vitro assay have similar flow. 
  
B A 
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Figure 5. Vesicle pool and three neurotransmitter releases [31, 32]  Left: The three functionally 
defined pools of synaptic vesicles are shown. The estimated pool sizes are determined in cultured 
hippocampal neurons. Right: (a) Evoked synchronous release from wild-type synapses. (b) Evoked 
asynchronous release from Syt1-deficient synapses. (c) Spontaneous ‘mini’ release. 
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Figure6. Steps of biotinylated quartz surface with different molecules. First silanol(N-(2-
AMINOETHYL)-3-AMINOPROPYLTRIMETHOXYSILANE) is treated on the clean quartz 
surface. Next mixture of mPEG and BiotinPEG are connected to the end of amine group of silanol. 
Later, neutravidin is loaded. The specific binding amount can be changed by varying the ratio 
between mPEG and BiotinPEG or the amount of neutravidin to be loaded. 
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Abstract 
Cholesterol is a major component of biological membranes and is known to affect 
vesicle fusion. However, the mechanism by which cholesterol modulates SNARE-
dependent intracellular fusion is not well understood. Using the fluorescence assay and 
employing dye-labeled SNAREs and the fluorescent lipids, we dissected cholesterol 
effects on individual fusion steps including SNARE complex formation, hemifusion, pore 
formation, and pore dilation. At physiological high concentrations, cholesterol stimulated 
hemifusion as much as 30-fold, but its stimulatory effect diminished to 10- and 3-folds 
for subsequent pore formation and pore expansion at 40 mole%, respectively. Therefore, 
the results show that cholesterol serves as a strong stimulator for hemifusion but acts as 
mild stimulators for pore opening and expansion. Strong stimulation of hemifusion and 
mild stimulation of pore formation are consistent with the fusion model based on the 
intrinsic negative curvature of cholesterol. However, even a milder effect of cholesterol 
on pore expansion is contradictory to such a simple curvature-based prediction. Thus, we 
speculate that cholesterol also affects the conformation of the transmembrane domains of 
SNAREs, which modulates the fusion kinetics.  
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Introduction 
Vital cellular processes such as neurotransmission, fertilization, and trafficking 
require membrane fusion[54-56]. SNAREs are believed to be the core components of the 
intracellular membrane fusion machinery[6, 9, 57]. Molecular recognition of a v-SNARE 
on a cargo vesicle with a t-SNARE on the target membrane leads to formation of a core 
complex[10, 11, 58-60]. This, in turn, brings about the assembly of a supramolecular 
structure of multiple SNARE complexes that spans two opposing membranes[61, 62]. 
There is overwhelming evidence that SNARE-mediated fusion transits through a 
hemifusion state in which lipids in the proximal leaflets are allowed to be intermixed but 
those on the distal leaflets are not[22, 63-68].  
Cholesterol is a major constituent of the biological membranes, occupying significant 
fractions of lipids in cellular membranes. In synaptic vesicles, for example, cholesterol is 
a dominant lipid species whose content reaches as much as 40% of the total lipids[69]. 
Cholesterol and its analogues are shown to play important roles in modulating exocytosis. 
Depletion of cholesterol out of isolated cortical vesicles from sea urchin eggs[70], or out 
of a cell-free exocytosis system from PC-12 cells[71], significantly impairs the release, 
strongly suggesting that cholesterol is essential for Ca
2+
-regulated exocytosis. Extraction 
of ergosterol is shown to inhibit plasma membrane fusion for pheromone secretion in 
mating yeast[72], again indicative of a positive role.  
Cholesterol may modulate SNARE-dependent membrane fusion in two different ways. 
Firstly, cholesterol may regulate the lateral distribution of SNAREs in the membrane[71, 
73].  ecently, it has been hotly debated if the distinctive domains called “lipid rafts,” 
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which are rich in cholesterol and sphingomyelin, exist in cell membranes[74, 75]. 
Nevertheless, it was proposed that SNAREs partition into the lipid rafts[76, 77]. The idea 
is now disputed by other experimental results[78]. Cholesterol is shown to promote 
crowding of the neuronal t-SNARE Syntaxin via the protein-protein interaction in the 
isolated plasma membrane of PC-12 cells without involving the rafts[73]. Potential 
relevance of such cholesterol-driven Syntaxin clusters to vesicle fusion was demonstrated 
experimentally[71]. Secondly, cholesterol is traditionally viewed as a lipid of the 
negative spontaneous curvature[79, 80]. Thus, cholesterol can either promote or inhibit 
the fusion steps depending on the curvature characteristics of the intermediates. For 
example, cholesterol promotes hemifusion, but inhibits pore formation in a protein-free 
membrane fusion. For SNARE-mediated fusion, it has been shown that the replacement 
of cholesterol by other amphiphilic molecules of negative curvature restores the extent of 
fusion in cortical vesicles[70], suggesting that the curvature plays a role. 
Cyclodextrin derivatives have the capacity of extracting cholesterol from the cell 
membranes[81-83].  Up to now, information of cholesterol function in exocytosis was 
almost entirely based on chemical extraction of cholesterol by methyl-β-cyclodextrin. 
With this method, however, the selective extraction of cholesterol from the desired 
membrane was nearly impossible. Moreover, the results were often ambiguous because 
cholesterol depletion may affect other factors, including the regulatory proteins, whereby 
making the delineation of exact roles of cholesterol in exocytosis is difficult. 
In this work, we attempted to analyze cholesterol function in SNARE-mediated 
fusion in a more defined and controllable setting. We employed an in-vitro fluorescence 
fusion assay in which fluorescence-labeled recombinant SNAREs, as well as fluorescent 
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lipids, were used[61]. This method made it possible to separately study SNARE complex 
formation, inner and outer leaflet mixing, and pore dilation (Fig. 1 A). This method 
allowed us to dissect the effects of cholesterol on individual fusion steps. The results 
show that cholesterol modulates individual fusion steps differently. The maximal positive 
effect is on hemifusion, and the negative effect is on pore formation and expansion. The 
analysis suggests that the cholesterol effects on SNARE-mediated fusion cannot be fully 
accounted for by its spontaneous curvature. Cholesterol appears to directly modulate the 
conformation of the transmembrane domains of SNAREs, thereby differentially 
modulating individual fusion steps. 
 
Results 
In this work, we studied a yeast SNARE family that plays a role in trafficking. 
Yeast SNAREs share functional and structural similarities with neuronal SNAREs that 
are involved in the neurotransmitter release. The t-SNARE proteins Sso1p and Sec9 are 
the counterparts of neuronal Syntaxin 1A and SNAP-25, respectively. Sso1p has a 
transmembrane domain that anchors the t-SNARE to the membrane. Snc2p is a v-
SNARE, a neuronal synaptobrevin (VAMP) analog [55, 84, 85].  We used shorter 
versions of t-SNAREs Sso1pHT and Sec9c for simplicity[86]. Sso1pHT lacks the N-
terminal regulatory Habc domain and Sec9c contains the homologous region to SNAP-25. 
Cholesterol stimulates lipid mixing 
To investigate the effect of cholesterol (Chol) on SNARE-mediated membrane fusion, 
we incorporated cholesterol into our vesicles.  Although ergosterol is a naturally 
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occurring, predominant sterol in yeast membranes [87], we decided to use cholesterol 
because of the technical difficulties with ergosterol in SNARE reconstitution. The t-
SNARE protein Sso1pHT was reconstituted into the 100 nm vesicles of 
POPC:DOPS:Chol in molar ratios of X:15:Y, where X and Y were adjusted to achieve 
the desired Chol content (Fig. 1 B).  The v-SNARE protein Snc2p was reconstituted into 
a separate population of vesicles of the same lipid composition. However, this 
composition contained 1.5 mole% each of NBD-PS and Rhodamine-PE for the 
fluorescence detection of lipid mixing (Fig. 1 C). The lipid-to-protein ratio was kept at 
200:1 for all samples. In the lipid-mixing assay, membrane fusion resulted in the 
recovery of NBD fluorescence due to the increase of the average distance between the 
fluorescence donor and the acceptor. When the Sso1p vesicles were mixed with the 
Snc2p vesicles without the t-SNARE light chain Sec9c, no lipid mixing was observed. 
This indicated Sec9c was required for fusion. Therefore, membrane fusion can be 
conveniently initiated by simply adding Sec9c into the mixture of the v- and t-SNARE 
vesicles. 
When Sec9c was added to the mixture, an increase of the NBD fluorescence signal 
was observed, indicating fusion happened (Fig. 2A). Lipid mixing was accelerated as the 
cholesterol content increased. For the quantitative comparisons, we arbitrarily used the 
equation representing the second-order kinetics to fit the time traces of the fluorescence 
changes. The analysis showed that the rate of lipid mixing, which was approximated with 
the inverse of the half time t1/2, increased exponentially as a function of cholesterol (Fig. 
2B). There was only a small increase at 10 mole% cholesterol. But the rate was enhanced 
3-, 8-, and even 20-folds at 20, 30, and 40 mole% cholesterol when compared with the 
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rate in the absence of cholesterol.  Therefore, the results show that cholesterol is a highly 
effective stimulator for lipid mixing at the physiological high cholesterol conditions. 
Inner vs. outer leaflet mixing 
There is overwhelming evidence that SNARE-mediated membrane fusion transits 
through a hemifusion state in which outer leaflets are mixed but the inner leaflets remain 
intact. Because the fluorescent lipids were expected to be distributed equally in the inner 
and outer leaflets, the observed total lipid mixing represented the average of outer leaflet 
mixing and inner leaflet mixing. To measure inner leaflet mixing separately, we treated 
the v-SNARE vesicles with sodium dithionite. Under a controlled condition, sodium 
dithionite reduces NBD attached to the lipid head group in the outer leaflet to a non-
fluorescent derivative while leaving NBD in the inner leaflet largely unaffected [22]. 
When Sec9c was added to the mixture of the dithionite-treated v-SNARE vesicles and the 
Sso1pHT vesicles, an increase of the fluorescence signal was observed, indicating that 
inner leaflet mixing occurred (Fig. 3A). This time, cholesterol again increased the rates of 
inner leaflet mixing but not as drastically as it did for total lipid mixing (Fig. 3B). Inner 
leaflet mixing changed little when cholesterol was less than 20 mole%, but the rates were 
increased 3-fold and 12-fold, respectively, for 30 and 40 mole% cholesterol. Now, the 
results for outer leaflet mixing can be readily obtained by simple subtraction of the time 
trace of the inner leaflet mixing from that of total lipid mixing [63]. The stimulation of 
outer leaflet mixing by cholesterol was very strong, reaching astonishing 15- and 30-folds 
at 30 and 40 mole%. Therefore, the analysis shows that cholesterol enhances outer leaflet 
mixing much more dramatically than it does inner leaflet mixing. 
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Effect of cholesterol on pore expansion 
The merging of two inner leaflets should be concomitant with formation of the fusion 
pore. Inner leaflet mixing measured with the dithionite method can therefore be 
considered a good measure of formation of fusion pore. However, what lipid mixing 
cannot tell us is the size of the fusion pore. Lipid mixing would be allowed, even if the 
pore is too small, to permit the passage of peptide or protein cargoes. We assessed the 
formation of the large functional pore with a FRET method employing C-termini labeled 
v- and t-SNARE [61] as an alternative method for content mixing (Fig. 1A). 
To observe FRET between one C-termini-labeled acceptor and donor, one of the dyes 
must cross the pore so that the acceptor and the donor can come at least within 50–60Å 
from each other. Otherwise, the two dyes are separated by at least the thickness of the 
two bilayers, which would be more than 100Å. Therefore, observation of FRET here 
would reflect the presence of a sufficiently wide pore that allows the passage of a few 
polar amino acids, plus the dyes, at the C-terminal end of the transmembrane domains.  
For FRET, cysteine-free versions of Sso1pHT and Snc2p were used to generate two 
C-terminal mutants: Sso1pHT R290C (Ct) and Snc2p S115C (Cv). The Sso1pHT mutants 
were derivatized with fluorescence donor Cy3 maleimide. The Snc2p mutants were 
reacted with acceptor Cy5 maleimide. We first reconstituted the mixture of Cv-Cy5 and 
unlabeled Snc2p in the ratio of 1:3 into one population of vesicles. These vesicles were 
then reacted with another population of vesicles containing Ct-Cy3 and unlabeled 
Sso1pHT in the ratio of 1:3. In this experiment, we diluted the labeled proteins with the 
corresponding unlabeled wild-types to avoid the potential complications arising from 
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self-quenching [61]. When Sec9c was added to the reaction, an increase of the 
fluorescence intensity in the acceptor channel (Cy5) (Fig. 4A) and a decrease of the 
fluorescence intensity in the donor channel (Cy3) were observed (data not shown). The 
results show that the distance between Cy5 and Cy3 was decreased, due to the co-
localization of v- and t-SNARE TMDs in the same aqueous compartment.   
Cholesterol only modestly increased the rate of C-C FRET. The rates were 
increased only two and three-folds at 30 and 40 mole% cholesterol, respectively (Fig. 4B). 
It is noteworthy that inner leaflet mixing was largely concomitant with C-C FRET when 
cholesterol content was less than 20 mole%. However, the latter became slower than the 
former at higher cholesterol concentrations. Therefore, the results show that cholesterol is 
not as effective in dilating the pore as it is in opening the small pore. 
Effect of cholesterol on SNARE assembly. 
Cholesterol is thought to influence the lateral distribution of SNAREs. It is also 
possible that cholesterol alters membrane topologies of the juxtamembrane regions of 
SNAREs that are proposed to regulate SNARE complex formation [88]. Therefore, we 
asked if SNARE complex formation is affected by cholesterol in the membrane. The 
kinetics of SNARE assembly was assessed with fluorescence resonance energy transfer 
(FRET) employing dye-labeled SNAREs. The N-terminal residues, amino acid 185 of t-
SNARE Sso1pHT and amino acid 13 of full-length v-SNARE Snc2p (amino acids 1–
115), were changed to cysteines. The cysteine mutants were labeled with fluorescence 
donor Cy3 and acceptor Cy5, respectively. Labeled Sso1pHT and labeled Snc2p were 
reconstituted into two separate populations of the vesicles of POPC, DOPS, and Chol. 
27 
 
When the SNARE complex was formed, t-SNARE captured the v-SNARE and the 
distance between the Cy3 on Sso1pHT and Cy5 on Snc2p decreased. Without Sec9c, the 
FRET was negligible. An addition of Sec9c increased the donor fluorescence rapidly in 
time, reporting association of v- and t-SNARE vesicles (Fig. 5A). The time traces of the 
fluorescence signal were fitted well with the equation representing the second-order 
kinetics. An addition of cholesterol did not change the formation time of SNARE 
assembly much when the cholesterol content was less than 20 mole% (Fig. 5B). However, 
cholesterol promoted the rate by factors of two and six at 30 and 40 mole%, respectively. 
Therefore, the results show that cholesterol promotes SNARE complex formation as well, 
although the stimulation was much less than it was for lipid mixing. 
 
Discussion 
The combined fluorescence assays employing fluorescent lipids and labeled 
proteins made it possible to dissect the effects of cholesterol on the individual fusion 
steps in unprecedented detail. We were able to observe the cholesterol effects on SNARE 
complex formation, hemifusion, fusion pore opening, and pore expansion. The results 
showed that individual fusion steps were all stimulated by cholesterol but to different 
extents. The maximal effect was seen at the hemifusion step. Remarkably, hemifusion 
accelerated as much as 30-fold in the presence of 40 mole% cholesterol. However, the 
stimulatory effect trickled down to only a three-fold increase for pore expansion. There 
was also a six-fold increase of the SNARE complex formation.  
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 The fact that stimulation by cholesterol was successively reduced along the fusion 
pathway following hemifusion was quite intriguing. It suggests that cholesterol 
negatively impact the rate constants for fusion pore formation, as well as for its 
expansion. Such fusion step-specific effects of cholesterol, i.e., stimulatory for 
hemifusion and the lesser stimulation for fusion pore formation, appear to be consistent 
with the prediction based on the cholesterol’s intrinsic negative spontaneous curvature. 
Hemifusion involves creation of negatively curved surfaces. Therefore, the inverted cone-
shaped cholesterol would stabilize the transition state for the hemifusion step. In contrast, 
fusion pore formation requires formation of positively curved surfaces, for which 
cholesterol is expected to be unfavorable.  
 Meanwhile, dilation of the fusion pore accompanies the relaxation of the acute 
positive curvature at the small pore stage. For this reason, cholesterol is expected to serve 
as a promoter for pore dilation. In fact, such a positive effect of cholesterol on pore 
expansion has been seen for membrane fusion induced by influenza hemagglutinin [89], 
as well as for protein-free membrane fusion [90]. For SNARE-mediated fusion, however, 
it appears that cholesterol stimulated pore dilation only very mildly, which is 
contradictory to the prediction based on the cholesterol’s spontaneous negative curvature. 
What would then be the molecular basis for such a minimal effect of cholesterol on pore 
expansion? It is highly likely that pore expansion is structurally and energetically coupled 
to heteromeric association of v- and t-SNARE TMDs. One possible scenario is that 
cholesterol does not favor the association of v- and t-SNARE TMDS, buttressing the 
expansion of the pore.   
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   Our results show cholesterol stimulates SNARE complex formation. However, 
this effect cannot fully account for the dramatic stimulation of hemifusion. It was 
previously shown that cholesterol has the ability to affect the lateral distribution of 
SNAREs [71, 73] that could influence the kinetics of SNARE assembly. There are also 
other reasons that might have contributed to the acceleration of SNARE assembly by 
cholesterol. First, the strong stimulation of hemifusion could reduce the rate of the 
dissociation of the docked vesicles (Fig. 1A), which would result in a faster overall 
reaction rate for complex formation. Second, there are unknown fractions of t- and v-
SNAREs that do not participate in membrane fusion but assemble into the complex after 
the completion of fusion, specifically after pore expansion. Therefore, the rate of SNARE 
complex formation partly reflects the rate of pore expansion that exhibits net stimulation 
by cholesterol. It appears paradoxical that the rate of outer leaflet mixing is faster than 
SNARE complex formation at 40 mole% (Fig. 5). This seemingly counterintuitive result 
can be also attributed to the same belated SNARE complex formation. The newly 
developed single-fusion assay [65], which can dissect the individual fusion steps for a 
single fusion event, might be an adequate tool to address such complex issues inherent 
for the ensemble assays. In addition, C-C FRET reflects not only association of the 
TMDs of v- and t-SNAREs participating in fusion but also the co-localization of 
SNAREs not participating in the fusion reaction. Therefore, C-C FRET has its short-
comings as a general method to detect the expansion of the fusion pore. 
 Recently, it has been found the hemifusion state is an important intermediate that 
serves as a substrate for the fusion activators [91, 92]. For example, sea urchin cortical 
granules are hemifused with the egg plasma membrane prior to fusion [92]. In neurons, 
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the majority of synaptic vesicles are found to be at the hemifused state on the presynaptic 
plasma membrane[66, 93]. In this work, cholesterol is shown to be highly effective in 
promoting hemifusion. Therefore, cholesterol may play a role in easing formation of the 
primed hemifused state waiting for the fusion trigger. On the other hand, cholesterol may 
also work as a negative regulator for fusion pore formation, rendering the improved 
opportunity for the regulator proteins to be able to control membrane fusion tightly[70, 
94].  
 Very recently, it was discovered that SNAREs are involved in homotypic fusion 
of lipid droplets, which has implications in obesity as well as in diabetes [95]. Fusion 
between two lipid droplets involved just hemifusion and no pore formation. Therefore, it 
is interesting to speculate what the effects of cholesterol would be on this medically 
important fusion event. 
 In summary, the fluorescence fusion assays reveal that cholesterol dramatically 
stimulates membrane hemifusion but mildly stimulates fusion pore opening and widening. 
The results show that the cholesterol effect cannot be fully explained with the intrinsic 
negative curvature and that the effect on the protein conformation must be considered, 
too.   
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Methods 
Plasmids and site-directed mutagenesis  
DNA sequences encoding Sso1pHT (amino acids 185-290 of Sso1p) and Snc2p 
(amino acids 1-115) were inserted into the pGEX-KG vector between EcoRI and HINDⅢ 
sites as N-terminal glutathione S-transferase (GST) fusion proteins. Sec9c (amino acids 
401-651 of Sec9) was inserted into pET-24b(+) between NdeⅠ and XhoⅠ sites as a C-
terminal His6-tagged protein. To introduce a unique cysteine residue for the specific dye 
attachment, native cysteine 266 of Sso1pHT was mutated to alanine. A QuickChange 
Site-Directed Mutagenesis Kit (Stratagene) was used to generate cysteine. DNA 
sequences were confirmed by the Iowa State University DNA Facility. 
Protein expression and purification   
Expressions of the yeast SNARE proteins were achieved by employing 
Escherichia coli BL21 (Novagene). The cells were incubated at 37°C for approximately 
3–4 hours in LB medium with 100㎍/㎕ ampicillin. After adding IPTG (Isopropyl-β-D-
thiogalactopyranoside) for induction, the cells were grown for an additional five hours at 
16°C. Cells were then harvested through centrifugation at 6,000rpm for 10 minutes. 
Purification of the GST fusion proteins was performed through affinity chromatography 
using glutathione-agarose beads (Sigma). Cell pellets were resuspended in PBS buffer 
(phosphate-buffered saline, pH 7.4, with 0.5% Triton X-100 (v/v)) with 2mM 4-(2-
aminoethyl) benzenesulfonyl fluoride (ABESF), and 5mM dithiothreitol (DTT). Cells 
were then broken by sonication and centrifuged at 15,000rpm for 20 minutes at 4°C. The 
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supernatant was mixed with glutathione-agarose beads in the resuspension buffer and 
nutated at 4°C for 120 minutes. The protein-bound GST beads were washed excessively 
with washing buffer (PBS, pH7.4), and the protein was cleaved by thrombin in cleavage 
buffer (50 mM Tris-HCl, 150mM NaCl, pH 8.0). We added 0.8% n-Octylglucoside (OG) 
in the cleavage buffer for Sso1pHT and full-length Snc2p. ABESF was added to the 
protein after the cleavage (2mM final concentration).  
The His6-tagged protein Sec9c was expressed in E. coli Rosetta (DE3) pLysS. For 
purification, cells were resuspended in lysis buffer (PBS buffer with 20 mM imidazole, 
0.5% Triton X-100, 2mM AEBSF, pH 7.4). After sonication, the supernatant was mixed 
with nickel-nitrilotriacetic acid-agarose beads (Qiagen) in lysis buffer. The mixture was 
nutated for binding at 4°C for 120 minutes. After binding, the beads were washed six 
times with washing buffer (PBS buffer with 20mM imidazole, pH 8.0). They were then 
washed with another washing buffer (PBS buffer with 250mM imidazole, pH 8.0). All 
proteins contained 10% glycerol as a cryoprotectant and were kept at -80°C. 
Making vesicles and reconstituting SNAREs  
A mixture of POPC (1-palmitoyl-2-dioleoyl-sn-glycero-3-phosphatidylcholine), 
DOPS (1,2-dioleoyl-sn-glycero-3-phosphatidylserine), and cholesterol in chloroform, in 
an appropriate proportion, was dried in a vacuum and resuspended in a buffer (25mM 
HEPES/KOH, 100 mM KCl, pH 7.4). Protein-free large, unilamellar liposomes (~100 nm 
in diameter) were prepared by extrusion through polycarbonate filters (Avanti Polar 
Lipids) after more than 10 iterations of freezing and thawing vesicles to make them big 
enough. For the lipid-mixing assay, the liposomes containing POPC, DOPS, cholesterol, 
33 
 
NBD-PS (1,2-dioleoyl -sn-glycero-3-phosphoserine-N-(7-nitro-2-1,3-benzoxadiazol-4-
yl)), and rhodamine-PE (1,2-dioleoyl-snglycero-3-phosphoethanolamine-N-(lissamine 
rhodamine B sulfonyl)) in the molar ratio of 82:15:0:1.5:1.5, 72:15:10:1.5:1.5, 
62:15:20:1.5:1.5, 52:15:30:1.5:1.5, and 42:15:40:1.5:1.5 were prepared following the 
procedure described above. Sso1pHT was reconstituted to the non-fluorescent vesicles 
while Snc2p was reconstituted to the fluorescent vesicles. Proteins were mixed with 
vesicles at a protein/lipid molar ratio of 1:200 at 4°C for 20 minutes. The protein/lipid 
mixture was diluted two times to make the concentration of OG below the critical micelle 
concentration. The liposomes were then dialyzed overnight against dialysis buffer (25 
mM HEPES/KOH, 100 KCl, 5% (w/v) glycerin, pH 7.4) at 4 °C. After reconstitution, the 
samples were centrifuged at 5,000g for ten minutes to get rid of any protein-lipid 
aggregates. 
Total and inner leaflet fusion assay  
Sso1pHT, Snc2p and Sec9c were used for lipid-fusion assay. In a quartz cuvette, the 
Sso1pHT-reconstuted vesicles were mixed with Snc2p-reconstituted vesicles. The total 
lipid concentration was 0.4 mM. The fusion reaction was initiated by adding Sec9c and 
HEPES buffer (pH7.4, with 5% glycerol (w/v), HEPES, KCl), which made the total 
volume 1   μl. The fluorescence signal from donor emission frequency was detected by a 
Varian Cary Eclipse model of a fluorescence spectrophotometer under the temperature of 
35°C. To reach the maximum fluorescence intensity (MFI), 1% reduced-Triton solution 
was applied after 3600 seconds.  
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The inner leaflet mixing assay was modified from the method developed by Meers et 
al [96]. The method is based on the fact that sodium dithionite reacts more rapidly with 
NBDs in the outer leaflet than those in the inner leaflet. By controlling the time and 
amount of dithionite the reaction could be limited to the outer leaflet. Small aliquots of 
100 mM sodium dithionite in 50 mM Tris buffer (pH 10) were added to the v-SNARE 
vesicles until a desired reduction of NBD was achieved. The reaction was monitored at 
35°C by scanning the fluorescence signal for 15 minutes from 500 to 700 nm with the 
excitation at 460 nm. Typically, the reduction was complete in 10 minutes and no more 
change of the spectrum was observed. The vesicles with reduced NBDs in the outer 
leaflets were subjected to the lipid-mixing assay described above. To make sure that the 
percentage of MFI was independent of the extent of the NBD reduction, the inner leaflet 
mixing assay was performed at the level in which 55% and 65% of NBDs were reduced.  
The change of the fluorescence intensity in time was fitted with the equation,  
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where [P] is the concentration of product, C0 is the initial concentration of the reactant, 
and k1 is the rate constant. The equation represents the second-order kinetics.  
N-N and C-C FRET assay  
Sso1pHT E185C and Sso1pHT R290C proteins were labeled with Cy3 maleimide, 
and Snc2p P13C and Snc2p S115C proteins were labeled with Cy5 maleimide 
(Amersham) after thrombin cleavage. The free dyes were removed from the proteins by 
(1) 
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using PD-10 desalting columns (Amersham). These proteins were reconstituted into 
vesicles with the lipid-to-protein ratio of 200:1. The fusion assay was carried out under 
identical condition to the procedure described above. The detection was achieved at two 
channels with the excitation wavelength of 555 nm and emission wavelengths of 570 nm 
and 668 nm. 
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Figures and Captions 
Figure1. A proposed fusion pathway and the preliminary characterization of SNARE-reconstituted 
vesicles. (A) A pathway for SNARE-mediated fusion is shown. The green and brown sticks represent 
v- and t-SNAREs, respectively. The red ball is the fluorescence donor and the blue is the fluorescence 
acceptor. The pink and yellow dots on the membrane are NBD-PS and rhodamine-PE, respectively. 
(B) An electron micrograph of the v-SNARE-reconstituted vesicles containing 40% of cholesterol. 
The vesicles were stained with 1% phosphotungstic acid on the carbon grids. The size of the vesicle 
averaged over more than 100 individual vesicles was 90 ± 15 nm, which was nearly the same as the 
vesicles without cholesterol. The small circles on the left were the staining artifacts. (C) The variation 
of the reconstitution efficiency as a function of cholesterol. After the reconstitution of the dye-labeled 
SNAREs, the fluorescence intensities were measured. The protein reconstitution efficiency was 
nearly invariant for all cholesterol concentrations. 
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Figure2. Lipid mixing at various cholesterol concentrations (A) Fluorescence lipid-mixing assay of 
SNARE-mediated membrane fusion. Fluorescence change for lipid mixing was normalized with 
respect to the maximum fluorescence intensity (MFI) obtained by adding 0.1% reduced Triton x-100. 
The change of the fluorescence intensity in time was fitted with Eq. 1. (B) Rates of lipid mixing at 
various cholesterol concentrations. The rate was approximated by the inverse of the half-life (t1/2)
-1
 
and the data were normalized with respect to the rate at the 0% cholesterol. The error bars were 
calculated on the basis of five independent measurements with five separately prepared vesicle 
samples. The error bars indicate the standard errors of the mean (SEM). 
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Figure3. Outer leaflet mixing versus inner leaflet mixing at various cholesterol concentrations (A) 
Inner leaflet mixing assay. The fluorescence changes in time were fitted with the second-order 
kinetics and the best fits are shown as the solid lines. (B) Outer vs. inner leaflet mixing. The rates, 
which are defined as the inverse of the half-life, were normalized with respect to the rate at 0% 
cholesterol. Outer leaflet mixing Po was calculated by using this equation: Po= 2PT - PI, where PT is 
the percentage for total lipid mixing and PI is the percentage for inner leaflet mixing. The error bars 
were calculated on the basis of at least five independent measurements. 
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Figure4. C-to-C FRET at various cholesterol concentrations (A) The intensity changes of donor 
fluorescence were fitted with Eq. 1, representing the second-order kinetics. The solid lines were the 
best fits. (B) The rates of C-C FRET mixing were compared with those of inner leaflet mixing. The 
data were normalized with respect to the rate of inner leaflet mixing at 0% cholesterol. The error 
bars were calculated on the basis of at least five independent measurements. 
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Figure5. FRET assays of SNARE complex formation (A) The changes in the fluorescence intensity 
for the acceptor due to SNARE complex formation at various cholesterol concentrations. The time 
profiles were fitted with Eq. 1. The solid lines were the best fits. The FRET value (E), calculated with 
the equation E = IA/(IA+IB), was ~0.27 and the E values were approximately the same for all 
cholesterol concentrations. (B) The rates of the SNARE complex formation were compared with 
those of total mixing. The data were normalized with respect to the minimum rate of total lipid 
mixing at 0% cholesterol. The error bars were calculated on the basis of at least five independent 
measurements. 
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CHAPTER 3: CHOLESTEROL INCREASES DOCKING, LIPID 
MIXING, AND CONTENT RELEASE ON SNARE-MEDIATED 
MEMBRANE FUSION 
This work was done in collaboration with Jae-Kyun Song 
 
Abstract 
Cholesterol is one of important components in membranes and the content of 
cholesterol is very rich in the synaptic vesicle and plasma membrane, reflecting the 
importance of cholesterol in neurotransmitter release. Here we show the effect of 
cholesterol in the specific steps of fusion: docking, lipid mixing, spontaneous fusion, and 
Ca
2+
-triggered fusion. Cholesterol enhances the kinetics of all these steps. Cholesterol on 
both sides of the vesicles is required for content mixing. In addition, cholesterol helped 
Syntaxins assemble to form higher oligomers meanwhile the higher oligomer ratio of 
Vamp was not affected by cholesterol content.   
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Introduction 
Cholesterol is one of the essential components in the eukaryotic membrane. The 
amount of cholesterol contents varies among cells. In endoplasmic reticulum(ER), even 
though cholesterol is synthesized there, cholesterol content in the ER membrane is less 
than 5%. Usually an intracellular membrane has lower concentrations than a plasma 
membrane; human erythrocyte has even 45mol% of cholesterol [97]. In neuronal synapse, 
vesicles contain 40mol% of cholesterol and 20mol% of plasma membrane is composed of 
cholesterol [69, 98].  
The cholesterol in the membrane changes the properties of membrane such as fluidity, 
permeability, phase, curvature and so on. Cholesterol is perpendicularly located into the 
bilayer. The hydroxyl group of cholesterol resides next to the head group of 
phospholipids while the 4 ring structures are next to the hydrocarbons of phospholipids. 
Even though a hydroxyl group of cholesterol is interacting with a carbonyl group of 
phospholipid, they don’t form a tight complex together in that cholesterol molecule is 
tumbling faster (τc=  .1ns) than phospholipid (τc= 1~10ns) [99]. Due to the space filling 
by cholesterol, the upper portion of phospholipid hydrocarbons tend to have more trans-
conformation; hence, the bilayers became more ordered, refered to as a ‘special ordering 
effect’, and more condensed [100]. As a result, the thickness of the bilayer increases (up 
to 16 carbons) and permeability is reduced [101]. Water penetration is reduced in the 
presence of cholesterol by 2.5Å [102]. In addition, cholesterol inhibits membrane from 
going toward s gel-state; instead it changes in Enthalpy and cooperativity to facilitate a 
liquid-crystalline phase.   
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Many studies have shown that cholesterol is an essential component in the function of 
various membranes and even the activity of some proteins. For viral infectivity of HIV, 
Influenza, and Sendai virus, cholesterol is required for them to fuse with cells. In the 
cortical secretory vesicles, when cholesterol was removed, both the extent and kinetics of 
Ca
2+
-triggered fusion were reduced [103], which indicates that cholesterol affects both 
earlier steps like docking and later steps (such as pore opening and expansion) of fusion. 
Also in HIV fusion, cholesterol helped expand the pore and completeness of content 
release [89]. For an Acetylcholine receptor to function as an ion gate, cholesterol is 
required [104].  
 holesterol’s role can be one of three types; 1.  holesterol increases local protein 
concentration by forming cholesterol-rich domains, 2. Cholesterol changes the 
physicochemical properties of a membrane and 3. Cholesterol itself may 
directly/indirectly interact with proteins involved in exocytosis [105].   
In a previous study using yeast SNAREs as a fusion machinery, we experienced a slightly 
reduced increment of cholesterol effect on the later step of fusion, inner layer-mixing and 
FRET between two C-terminus of sso1 and snc2(CC FRET), compared to the increment 
effect for the earlier step, outer-layer mixing and FRET between two N-terminus of sso1 
and snc2(NN FRET) [106]. Furthermore, an earlier study [107] showed that cholesterol 
stabilizes the hemifusion step by resisting pore opening/pore expansion in oppositely-
charged vesicles. Since we used ensemble FRET in the previous study, it is possible that 
the signal from enhanced docking had an effect all the way to the pore openings; however, 
actually pore-opening/expansion could have been inhibited by cholesterol but the reduced 
signal simply screened by highly-increased signal coming from the docking number. 
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Therefore, if the signal were normalized by a respective docking number that couldn’t be 
achieved in an ensemble assay, the later step, pore-opening/expansion, could have been 
inhibited rather than enhanced by Cholesterol. It is still plausible that the later step was 
enhanced but the signal sensitivities of later steps were simply not as effective as those of 
the initial steps such as NN FRET or docking. So in this study, to determine the effect of 
Cholesterol at each step, apart from checking the docking numbers, the extent of lipid 
mixing and content mixing of neuronal SNARE-mediated liposome fusion using TIRF 
were examined. In addition, a photo-bleaching experiment was performed to determine 
the effect of Cholesterol on the distribution of Syntaxin1A and Vamp2.  Our results 
showed that cholesterol enhanced all of docking, lipid mixing and content mixing. 
Increasing the level of cholesterol resulted in more Syntaxin assembly but Vamp was not 
affected. 
 
Results 
Cholesterol enhanced overall lipid mixing without changing the incorporation rate 
of proteins. 
Over the lipid mixing assay the samples contained a 0, 20, or 40mol% cholesterol 
concentration. To check whether the reconstitution rate of SNARE protein became 
different in the presence of cholesterol in the vesicles, we compared the protein amount 
in vesicles containing various concentrations of cholesterol. Compared to an input 
amount of Syxtaxin1A, the incorporation rate for vesicles containing 0mol%, 20mol%, or 
40mol% cholesterol sample was around 70%. Also for Vamp2, the incorporation rate for 
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0mol%, 20mol%, and 40mol% cholesterol sample were around 80% (Figure1 A). This 
result indicates that the FRET enhancement did not result from different protein 
concentrations in the vesicles. 
After equal-molar samples of T and V-vesicles were mixed in a cuvette, the    T 
was measured at      using a  luorescence Spectrophotometer. The more cholesterol, the 
higher enhancement of FRET was obtained (Figure1 B). A cholesterol level greater than 
  % is known to destabilize vesicles, so we didn’t test at greater than 4 %, also the 
amount in the synaptic vesicles. The maximum enhancement was achieved when both of 
the vesicles contained cholesterol (Figure1 C and D).  
Cholesterol increases docking 
As indicated by the initial rate of ensemble FRET (Figure1 D), cholesterol 
enhanced mixing from the very beginning of the reaction. Here to check the docking rate 
of two vesicles in the absence/presence of cholesterol at each side, we used tethered 
vesicle systems with t-vesicles tethered on the slide through biotin-neutravidin 
conjugation, v-vesicle was loaded, incubated and then washed off the unbound portion 
(Figure2 A). Similarly to ensemble FRET (Figure 1 C and D), sample containing 
cholesterol on both t- and v-vesicle had most docking number. And cholesterol at the v-
site seems more effective in docking than that at the t-site (Figure 2 B). Even in the 
presence of Synaptotagmin, a 40% cholesterol level slightly increased the docking while 
a 20% of cholesterol level had a less obvious effect on docking in the presence of 
Synaptotagmin (Figure 2 E and F).  
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Cholesterol enhances lipid mixing 
For the docked vesicle pairs, the FRET value was calculated according to the 
equation, FRET= IA/(ID+ IA) where ID and IA are the respective donor and acceptor 
fluorescence intensities. The distribution is shown in Figure2 C where a sample (green 
line) with both containing 40% cholesterol has the most of the population in a higher 
FRET area. The area below the FRET distribution where FRET is above 0.5 shows that 
cholesterol facilitates lipid mixing (Figure2 D).  
Cholesterol stimulates Ca
2+-
 independent and dependent content release 
To check content release, t-vesicles containing 50mM Sulforhodamine B were 
tethered on the quartz slide. Upon loading of v-vesicles a Ca
2+
 -independent spontaneous 
content release was detected. After some incubation to achieve docking, the remaining v-
vesicles were washed off and Ca
2+
 ions were injected and followed by detection. 
Spontaneous fusion increased dramatically when 40% of cholesterol was incorporated 
into both of the vesicles (Figure3 A and C). Similarly, triggered fusion was at its 
maximum when both t- and v- vesicles contained cholesterol (Figure3 B and D).  
Syxtaxin clustering is enhanced in the presence of Cholesterol but not for Vamp 
To further investigate the effect on SNARE proteins, the clustering number of 
Syntaxin and Vamp was counted using a photobleaching assay that showed direct 
evidence of clustering. We labeled Cy5 dye at the end of a transmembrane domain in 
both Syntaxin and Vamp. Each protein was reconstituted into vesicles with low protein-
to-lipid ratio (1: 8,000,000) to isolate each cluster (Figure  4A).  The intensity of the Cy5 
signal was reduced in step-wise manner as it was photobleached (Figure 4B). As 
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cholesterol concentration in the vesicles increased, Syntaxin had tendency to assemble 
into higher oligomers (Figure 4C and E). Meanwhile the equilibrium between monomer 
and oligomer of Vamp wasn’t changed ( igure 4D and  ).  
Cholesterol reduced fusion delay time 
V-vesicles containing with or without 40mol% cholesterol were loaded onto 
supported bilayer containing 10mol% of cholesterol. Docking was achieved when the 
signal suddenly increased. Fusion delay time was defined as the time between docking 
and the starting point of signal decay due to the diffusion of lipidic dye in the v-vesicles. 
The docking number was the sum of all events. As shown previously, cholesterol 
enhanced total docking number (Figure 5 A, C, and E) possibly by preventing loosely 
tethered vesicles from leaving right, which we called “Dock and  un” ( igure    ). 
Similarly as in a tethered vesicle system, cholesterol also increased the lipid mixing in a 
planar bilayer system. Importantly, cholesterol facilitated the content release in that the 
profile of fusion delay time of cholesterol containing vesicles was shifted to in a 
decreasing direction. (Figure 5 B and D).   
 
Discussion 
Cholesterol is one of important components in cell membranes. The properties of 
cholesterol in bilayers have been investigated extensively. First, by residing in the 
phospholipid bilayers cholesterol itself affects the physicochemical properties of the 
bilayer. Cholesterol decreases an area per lipid molecule, called a condensing effect. 
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 Second, cholesterol together with sphingomyelin form a specific microdomain, called a 
‘lipid raft’. In our experiment we didn’t include sphingomyeline in our liposomes or 
planar bilayers. However, there are studies showing that only cholesterol rich domains 
may exist and cholesterol-rich domain is more ordered [108]. Cholesterol also binds to 
some proteins such as acetylcholine receptors. In membrane fusion and exocytosis, 
cholesterol has essential functions in changing both the extent and kinetics of fusion [89, 
103, 109, 110]. 
In this study, we examined the influence of cholesterol on docking, lipid mixing, 
Ca
2+
-independent pore opening, and triggered content release. Using an ensemble FRET, 
a single-vesicular study on tethered vesicle system and a planar bilayer system, we found 
that cholesterol enhances all those steps, consistent with previous literatures on other 
systems such as cell fusion, viral fusion or yeast fusion that also showed that cholesterol 
has positive effects on membrane fusion. It is noteworthy that in the content mixing step, 
cholesterol is needed on both sides to effectively open the pore. We also performed 
photobleaching experiments to check the assembly of SNARE proteins caused by 
cholesterol. While Vamp didn’t change in the oligomer ratio, Syxtaxin assembly 
increased with greater cholesterol content. With Syntaxin’s higher assembly due to 
cholesterol, we can intuitively think that this will increase the binding avidity of T-
vesicles toward V-vesicles. It is possible that thanks to this higher Syntaxin assembly, 
cholesterol could help tightly dock the coming v-vesicles toward the t-vesicle.  
Syntaxin is known to bind to cholesterol and Synaptotagmin may also bind to 
cholesterol [111] but not Vamp. However, Vamp is influenced by cholesterol. In a 
previous study from Shin Lab, it was shown that in the presence of cholesterol two 
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neighboring transmembrane domamins of Vamp change their conformations to make a 
parallel dimer from an open-scissors-like form [112]. By doing so, the negative curves 
are preferentially changed into positive curve to facilitate lipid mixing. In that paper, it 
was speculated that because of the thickening effect of cholesterol on the width of bilayer, 
the Vamp trans-membrane domains needed to change their positions to retain the 
hydrophobic interactions. Probably, Syntaxin probably uses a different mechanism 
because it directly interacts with cholesterol rather than just residing in the bilayer like 
Vamp.  
After docking occurs and SNARE complexes start to form, two membranes are in 
close proximity using the energy generated from the release of the SNARE complex. 
Hemifusion has already proven in several studies. It was expected and has been proven in 
oppositely-charged vesicles that cholesterol enhances the hemifusion steps of membrane 
fuson. Cholesterol also helps widening of fusion pores [89].  
We have shown that cholesterol only on the v-vesicle side is not by itself enough 
to cause content release, since cholesterol in the t-vesicle is also required. Cholesterol in 
the t-vesicle increased the clustering number of Syntaxin, so it is possible that cholesterol 
has a role in recruiting enough SNARE complexes to overcome the energy barrier not 
only for docking but also for pore opening. In terms of the number of SNARE complexes 
required for membrane fusion, many studies reported that a number of SNARE 
complexes up to 15 are required for fusion [113]. In contrast, it was also reported that one 
SNARE complex is enough to mediated membrane fusion [114]. However, they used 
small radius vesicle or nano disk that could induce fusion easily. Even so, more than 
three SNARE complexes were required to maintain the pore opening. 
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Recently two membrane fusion models; the proteinaceous pore model and the 
lipidic pore model have been reconciled in that the initial fusion pore is formed by 
proteins, followed by replacement of gap-junction like protein by lipid molecules and 
finally the lipidic fusion pore expands spontaneously due to its own fluidic nature [115]. 
According to this combined model, cholesterol maybe indirectly involved in the pore 
expansion step in which proteins are replaced into lipid molecules. With more cholesterol 
in the membrane, the proteins in the membrane interact with less phospholipids around 
them due instead to the interaction of cholesterol with the proteins. Protein-Syntaxins 
were preassembled in the pore possibly in the local cholesterol rich domain, or perhaps 
these Syntaxins simply interact with cholesterol than phospholipids. Therefore, in both 
cases, Syntaxins can be more easily substituted by phospholipids into the fusion pore 
structure than 1) in the case where removing proteins one by one in the fusion pore or 2) 
in the case in which phospholipids which need to fill up the newly forming lipidic pore 
were already interacting with distant proteins so that they were not as mobile as free non-
interacting phospholipids. 
    
Methods 
Vesicles and Reconstitution 
For the ensemble lipid mixing assay and the single lipid mixing assay, vesicles were 
made with a mixture of POPC (1-palmitoyl-2-dioleoyl-sn-glycero-3-phosphatidylcholine), 
15mol% DOPS (1,2-dioleoyl-sn-glycero-3-phosphatidylserine), with or without 20 or 
40mol% of cholesterol in chloroform. To label vesicles 1% DiD or DiI lipidic dye was 
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also contained. For the purpose of tethering the vesicles, 0.5mol% of Biotin-PE was 
included. 
For content mixing, donor vesicles were made with POPC, DOPS, and PIP2, 
Biotin-PEG either with or without cholesterol with a molar ratio of 86:12:1:1:0 or 
46:12:1:1:40. Acceptor vesicles were comprised of POPC, DOPS, and DiD also with or 
without cholesterol with a molar ratio of 95:4:1:0 or 55:4:1:40. The asymmetric 
distribution of DOPS was chosen consistent with our previous lab result [116]. 
For the photobleaching assay, vesicles were prepared with 0, 10, 20, and 40mol% 
cholesterol and POPC for the remaining part. 
Vesicle mixtures were dried with an air (Nitrogen) stream then put it into a 
vaccum dessicator overnight to completely dry out chloroform and other organic solvents. 
The dry lipids were hydrated by adding a buffer containing 25mM of HEPES and 
100mM of KCl (pH7.4). 50mM of Sulforhodamine B was also added in this HEPES-
containing buffer. Then 10 freezing and thawing iterations of vesicles were performed. 
Uniform large, unilamellar liposomes (~100 nm in diameter) were prepared by extrusion 
through polycarbonate filters (Avanti Polar Lipids). In the case of content mixing donor 
vesicles, vesicles were mixed with OG and Proteins added with a 1:200 molar ratio of 
Protein to Lipid, 1:400 for content mixing, or 1:8,000,000 for the photobleaching assay. 
This mixture was then diluted 1.5-2 times and dialyzed overnight against the same buffer.  
Ensemble Lipid mixing 
1  u  of DiI-containing T vesicle was mixed with a   P S-containing buffer at 
     and followed by waiting until the signal had no change due to temperature non-
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equilibrium. Then an equimolar solution of a DiD-containing V vesicle was combined 
into the mixture. The detection was made at      for     s.  
Slide preparation for TIRF  
Quartz slides were cleaned by 10% Alconox detergent solution, acetone, methanol, 
and piranha solution (1:4 hydro peroxide and sulfuric acid). The photobleaching assay 
was performed at this stage. For the other assays, aminosilane (N-(2-AMINOETHYL)-3-
AMINOPROP  T I  T O  SI    ) was treated on the cleaned quartz surface. 
Then an mP   and  iotinP   mixture was coated to connect to the end of the amine 
group of silanol.  ll the residues were then washed off and the slides were kept in -     
until used. Neutravidin(NTV) was then loaded and incubated. 
Content Mixing 
After attaching T vesicles containing 50mM of SB to NTV loaded channel, a v-
vesicle containing DID was loaded. At loading, first detection was done for a 
spontaneous fusion occuring right after docking. Then after incubation for 10min to allow 
sufficient docking, unbound V-Vesicles were washed out. 500uM of Calcium was 
injected while the detection was performed. Upon fusion, SB undergoes dequenching. 
Lipidic dye, DiD, in the v-vesicle was used to check the docking number.  
Photobleaching Assay 
The flow cell was first assembled and vesicles directly introduced onto the highly 
hydrophilic surface for at least 4 hours to form a lipid bilayer. Unbound vesicles were 
washed off by a fusion buffer with 20 times the volume of the flow cell. Just before 
56 
 
detection, an imaging buffer (1 mg/m  glucose oxidase,  .   mg/m  catalase,  .4 wt% β-
D-glucose and Trolox) was prepared and injected to avoid a fast photobleaching event 
and blinking events. Detection was initiated a few frames before the laser was turned on 
so as not to miss the very first signal. The CCD exposure time was set to 50 milliseconds 
and the trace was recorded for 500 frames. The trace was fitted by a NoRSE algorithm to 
count photobleaching steps. (NoRSE: Noise Reduction and State Evaluator for High-
Frequency Single Event Traces) 
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Figures and Legends 
 
Figure 1. Cholesterol enhance lipid mixing in an ensemble FRET assay (A) SDS-PAGE showing 
Syntaxin and Vamp incorporation amount into vesicles with different cholesterol molar 
concentration. (B) Effect of cholesterol on the kinetics of ensemble FRET assay. (C) Different kinetics 
according to the position of cholesterol. (D) Initial rates comparison from (C). 
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Figure 2. Cholesterol enhances docking and lipid mixing in a single FRET assay. (A) Schematic of 
tethered vesicle system for this single FRET assay. (B) Number of Docking (C) FRET distribution of 
docked vesicles with or without cholesterol on each side. (D) Area comparison in which the FRET 
distribution was above 0.5.  Docking number comparison with Synaptotagmin in the v-vesicle when 
(E) Cholesterol was 20%, and when (F) Cholesterol was 40%  
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Figure 3. Cholesterol facilitates content release. (A) Spontaneous Release; Accumulated Content 
release as soon as V-vesicles are loaded upon tethered T-vesicles. (B)Spontaneous fusion was 
normalized by docking. (C) Triggered Release; Accumulated Content release as soon as Calcium was 
loaded upon docked vesicles. (D) Triggered fusion normalized by docking. 
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Figure 4. Cholesterol helps Syntaxin cluster but not Vamp. (A) Fluorescent image of a planar bilayer 
before photobleaching. Each spot is a single molecule of cy5 dyes attached to Syntaxin or Vamp. (B) 
Examples of fluorescence photobleaching traces circled on (A). The inset number indicates the 
number of photobleaching steps. The fluorescence trace (blue line) fitted by NoRSE Algorithm (red 
line). (C and D) The oligomer distribution of Syntaxin and Vamp for various cholesterol 
concentrations (E and F). The tendency of higher Syntaxin and Vamp oligomer formation by 
cholesterol. (Photobleaching data were collected from 965, 995, 1059, and 1062 spots for Syntaxin 
and from 992, 1101, 1234, and 997 spots for Vamp.) 
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Figure 5. Docking and Fusion profiles. The v-vesicles are introduced on the lipid bilayer 
containing 10% cholesterol. The v-vesicle contains 0% cholesterol (A) or 40% cholesterol 
(B). Docking (red) is the sum of lipid mixing (green) and hemi-fusion (blue). The vesicle, 
which leaves after residing for just a few frames, is defined as ‘dock and run’ (magenta). 
The delay time before lipid mixing happens is shown in (B) and (D). The time-delay fitting is 
shown in red line. (E) The normalized docking was compared between (A) and (B).  (F) 
Normalized profiles of (A) and (B) is shown.  
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CHAPTER 4: α-SYNUCLEIN INHIBITS SNARE-DEPENDENT 
MEMBRANE FUSION IN THE DOCKING STEP 
This work was done in collaboration with Ying Lai 
 
Abstract 
α-Synuclein (α-Syn), a major component of Lewy bodies that are considered as a 
hallmark of Parkinson’s disease (PD), has been implicated in neuroexocytosis. 
Overexpression of α-Syn decreases the neurotransmitter release. However, the 
mechanism by which α-Syn inhibits the neurotransmitter release is still unclear. Here, we 
investigated the effect of α-Syn on SNARE assembly and SNARE-dependent liposome 
fusion using fluorescence methods. The results show that α-Syn inhibits bulk lipid mixing. 
Furthermore, mutants linked to familial PD A30P, A53T, and E46Kare less effective than, 
similar to, more than the wild-type in fusion-inhibition, respectively, correlating well 
with the rank order of their individual membrane affinities. A negatively-charged lipid 
that strongly favors α-Syn's membrane binding is also required for the fusion-inhibiting 
function. Finally, the single-vesicle fusion assay reveals that α-Syn specifically inhibits 
vesicle docking, without interfering with lipid mixing and pore opening. Thus, α-Syn 
may inhibit SNARE-dependent vesicle docking through membrane binding. 
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Introduction 
Neurotransmitter release is very tightly regulated and in this process, many 
proteins are involved in one or several steps (such as vesicle docking, priming, sensing 
Ca-influx, endocytosis). Identifying the role of these proteins is one of major tasks. Many 
of these proteins are involved in neurodegenerative diseases such as Huntington Disease, 
Schizophrenia, and Parkinson’s disease. Parkinson’s disease, the second dominant 
neurodegenerative disease,  is directly caused by Lewy bodies that are fibrils and consist 
primarily of α-Syn [117]. Some genetic studies also show that a mutation in α-Syn has 
been found in familial Parkinson’s disease [118, 119].  α-Syn is a small protein consisting 
of around 14  amino acids and is widely expressed in the brain. α-syn is an isoforms of 
three synucleins: α-Syn, β-syn, and γ-Syn, according to the genes. Alpha-synuclein KO 
shows little difference in neurotrasmitter release but a triple knock-out showed increased 
age-dependent release [120] probably because the other two isoforms have redundant 
roles.  Overexpression of α-Syn in chromaffin and rat-brain cells largely decreased the 
neurotransmitter release [121-123]. These studies indicate that α-synuclein plays a 
regulator role in neurotransmitter release. 
Neurotransmitter release at the synapse requires the fusion of vesicles with the 
presynaptic plasma membrane. It is believed that synaptic vesicle fusion is mediated by 
SNARE proteins. Target plasma membrane (t-) SNAREs Syntaxin 1A and SNAP-25, 
along with vesicle (v-) SNARE VAMP2 associate to form the SNAREpin that bridges 
two membranes and facilitates fusion [6, 10, 11, 57, 124]. Although it has recently shown 
that the C-terminal region of α-Syn interacts with VAMP2 and promotes SNARE 
assembly [125], this interaction appears to be a different function of α-Syn not affecting 
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the neurotransmitter release [126]. It was, however, shown that α-Syn reduces exocytosis 
in yeast and causes the decrease of the copy number of the SNARE complex in 
mammalian cells [127], raising the possibility that α-Syn might directly affect SNARE-
dependent fusion.  
In this work, we attempt to explore the direct impact of α-Syn on SNARE-
dependent membrane fusion in a more defined setting. The fluorescence fusion assay 
employing SNARE-reconstituted proteoliposomes reveals that SNARE-induced lipid 
mixing was systematically inhibited by the increasing concentration of α-Syn. The known 
pathotype mutants α-SynE46K, A53T, and A30P are shown to have a varying degree of 
membrane affinities, E46K being higher than, A53T being similar to, and A30P being 
lower than that of the wild-type [128]. Interestingly, it was found that the rank order of 
inhibition potency is α-Syn 46K >    T ≈ wild-type > A30P, consistent with the rank 
order of their membrane affinities. Furthermore, when the membrane binding affinity of 
α-Syn was eliminated by removing the phosphatidylserine (PS) from the membrane, α-
Syn was no longer effective in inhibiting lipid mixing. Finally, a single molecule study 
revealed that a-Syn inhibits vesicle fusion via affecting the docking step, but little effect 
on fusion pore opening. Our results thus suggest that membrane binding of α-Syn causes 
the inhibition of SNARE-dependent membrane fusion. 
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Results 
α-Syn inhibits SNARE-induced lipid mixing.  
Previous in vivo studies suggested that overexpression of α-Syn inhibits 
neurotransmitter release [121-123, 129]. Therefore, we asked if α-Syn interferes with the 
lipid mixing during membrane remodeling. To answer this question, we carried out the 
fluorescence lipid mixing assay, in which wild-type t-SNARE(1:1 mixture of SyxF and 
SNAP-25) was reconstituted to t-vesicles that contained 2mol% fluorescence donor lipid 
DiI, while wild-type VAMP2 was reconstituted to v-vesicles containing 2mol% 
fluorescence acceptor lipid DiD for the fluorescence detection of lipid mixing. With this 
set-up the fusion between t- and v-vesicles caused the increase of the acceptor DiD signal 
due to FRET (the red trace in Fig. 1A and FigureS1). To show that lipid mixing probed 
by FRET between DiI and DiD was SNARE-dependent we carried out lipid mixing in the  
presence of soluble VAMP2 (Vps, amino acids 1-96), which is often used as a 
competitive inhibitor for SNARE-dependent membrane fusion, showed complete 
inhibition of lipid mixing at 1 μ  (the black trace in  igure 1 ). Upon addition of α-Syn 
lipid mixing was dramatically inhibited, even at the concentration of  μ  (the yellow 
trace in  igure 1 ). With the increased concentration of α-Syn, the lipid mixing was 
attenuated progressively more (Figure 1A). The analysis of the initial rates of lipid 
mixing indicates that   μ  α-Syn can block SNARE-induced lipid mixing as much as 70% 
(Figure 1B). Because the lipid mixing is strictly SNARE-dependent, we can rule out the 
possibility that α-syn blocks SNARE-independent spontaneous fusion of membranes. 
Instead, we investigate the effect of α-syn on the cis SNARE complex formation. By 
looking at the FRET between each C terminus end of the Syntaxin 1A and Vamp2 
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( igure S  ), we found that α-Syn also inhibited cis SNARE complex formation 
although the inhibition was milder than that of lipid mixing (Figure. S2B and C).We also 
note that  a + does not affect α-syn's inhibition of lipid mixing (Figure. S3). Therefore, 
both lipid mixing and cis S     complex formation demonstrate that α-Syn attenuates 
SNARE-dependent membrane fusion. 
α-Syn pathotype mutants show parallel gain- and loss-of-functions in membrane 
binding vs. fusion inhibition.  
In vivo studies indicated that membrane binding ability of α-Syn may be 
correlated with its inhibition of the neurotransmitter release [123]. To investigate whether 
α-Syn’s membrane affinity is related to its inhibition of S    -dependent lipid mixing, 
we carried out the lipid mixing assays with three mutants of α-Syn, A30P, E46K, and 
A53T, which are linked to rare inherited PD [118, 130, 131]. NMR studies indicated that 
α-Syn    P has a decreased lipid affinity, while α-Syn E46K has an increased affinity 
when compared with that of the wild-type.  eanwhile, α-Syn A53T is similar to the 
wild-type in its membrane binding activity [128]. Interestingly, the lipid mixing assay 
revealed that α-Syn A30P was somewhat less effective in inhibiting SNARE-dependent 
lipid mixing than wild-type ( igure    and  ). In contrast, α-Syn E46K was a little more 
potent than the wild-type ( igure    and D).  eanwhile, α-Syn A53T showed little 
difference from the wild-type (Figure 2E and F). The results show a correlation between 
the α-Syn's membrane binding activity and its inhibitory activity for SNARE-dependent 
lipid mixing. Thus, membrane binding may be necessary for the inhibition of SNARE-
dependent membrane fusion by α-Syn. 
71 
 
Inhibition of SNARE-dependent lipid mixing by α-Syn requires negatively charged 
lipids. 
It is well known that α-Syn has very low affinity for uncharged membranes [132]. 
To further verify the correlation between the membrane binding affinity of α-Syn and the 
inhibition of lipid mixing, we carried out the lipid mixing assay with the neutral vesicles, 
in which the acidic phospholipids DOPS was omitted. As expected, with this neutral 
vesicle, we did not observe any inhibition in lipid mixing at various α-Syn concentrations 
within experimental errors (Figure3A and B). Thus, the results show that the negatively 
charged lipids and thus, membrane binding is required for α-Syn's fusion inhibiting 
activity. 
α-Syn inhibits lipid-mixing induced by a yeast SNARE family involved in trafficking. 
If α-Syn's fusion-inhibiting activity is mainly due to its membrane interaction we 
reason that α-Syn will inhibit lipid mixing by other SNARE systems. Thus, we 
investigated the effect of α-Syn on lipid mixing induced by a yeast SNARE family, which 
is involved in Golgi-to-plasma membrane trafficking in yeast [133, 134] and is distantly 
related to the neuronal SNARE family with only less than 30% sequence identities [2]. 
For this purpose, yeast t-SNARE Sso1p, the SyxF counterpart, was reconstituted to t-
vesicles, and v-SNARE Snc2p, the VAMP2 counterpart, was reconstituted to v-vesicles. 
The lipid compositions were the same as those for the lipid mixing assay with neuronal 
SNAREs. In the lipid mixing assay, the SNAP-25 counterpart, Sec9c was added into the 
t- and v- vesicle reaction mixture to initiate the fusion reaction (the black trace in Figure 
4 ). When α-Syn was included in the fusion reaction, a significant inhibition of lipid 
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mixing was observed (Figure 4A and B). In fact, the inhibition was stronger than it was 
for neuronal S    s ( igure 1). Thus, the results show that α-Syn's inhibition of 
membrane fusion is not specific to neuronal SNAREs, suggesting that its fusion-
inhibiting activity comes from a different mechanism from the direct α-Syn-SNARE 
interaction. 
α -Syn specifically inhibits vesicle docking. 
 lthough the ensemble lipid mixing data suggested that α-Syn inhibits vesicle 
fusion via membrane binding ability, we cannot conclude which fusion step α-Syn 
particularly inhibits. To address this question, we applied the single molecule FRET 
assay to investigate the effect of α-Syn in each step of vesicle fusion. Interestingly, we 
found that α-Syn significantly inhibited the vesicle docking (Figure 5A), but neither lipid 
mixing ( igure   ) nor content mixing ( igure S4  and  ).  urthermore, α-Syn mutants 
also showed similar inhibitory effects in vesicle docking step, coordinating well with 
their membrane binding ability (Figure 4C and D). The real-time vesicle docking assay 
with α-Syn and its mutants shows very similar inhibitory effect (Figure 5E). Thus, our 
results suggested that α-Syn specifically inhibit vesicle docking via binding to acidic 
membrane. 
 
Discussion 
There is compelling evidence that α-Syn buildup in cells interferes with 
exocytotic pathways: α-Syn block the ER to Golgi trafficking in yeast [133] and in 
mammalian cells [127, 134]. Overexpression of α-Syn in Chromaffin cells as well as in 
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mouse neurons inhibits release of neurotransmitters [121-123, 129]. Although it is most 
likely that α-Syn interferes with the exocytotic machinery, the molecular mechanism by 
which α-Syn blocks the exocytosis has not been known. In this work, using in vitro 
reconstitution, we show that α-Syn inhibits SNARE-dependent membrane fusion via 
affecting vesicle docking. 
It appears, however, that the inhibition of membrane fusion by α-Syn is not 
through the direct interaction with S    s, but it is rather through the α-Syn's 
membrane binding. A line of evidence supports this claim: (1) in the absence of the 
negatively charged lipid PS, which strongly favors α-Syn's membrane binding, the 
fusion-inhibiting activity of α-Syn is abrogated; (2) the gain-of-function mutant α-Syn 
E46K in membrane binding inhibits membrane fusion more than the wild-type, while the 
loss-of-function mutant A30P inhibits fusion less than the wild-type; and (3) it exhibits a 
strong inhibitory activity for even a distantly related SNAREs involved in yeast 
trafficking. 
It has been previously argued that inhibition of exocytosis by α-Syn represents its 
toxicity [129, 133]. If so, we might have expected that the familial PD-causing mutations 
A30P, E46K, and A53T gave stronger inhibition for SNARE-dependent lipid mixing. On 
the contrary, our results revealed that there is no clear correlation between its fusion-
inhibiting activity and disease-causing mutations. The findings here are short of revealing 
the pathogenic mechanism of familial PD. Therefore, we hesitate to conclude yet whether 
the fusion-inhibiting activity of α-Syn perhaps represents its toxicity or not. It is possible 
that the familial PD-causing mutants are just more susceptible to the cellular or 
exogenous factors that lead to transformation of α-Syn to protofibrils, which is believed 
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to be its disease-causing form [135] and their disease characteristics are not fully 
reflected in our results.  
 or α-Syn, the docking-inhibiting function is not necessarily in contradiction with 
its maintenance role proposed by Südhof and coworkers [125]. Their results suggest that 
α-Syn binds to v-SNARE VAMP2 to maintain a high level of the SNARE complex 
population in the neuron. However, very recent study showed that nano Molar range of 
monomer did not significantly inhibit membrane fusion and conversely similar 
concentration of oligomer affected the docking of two opposing membranes through the 
mechanism in which α -syn oligomer binds to Vamp2 and reduced the available Vamp2 
pool for SNARE complex formation [136]. Meanwhile, several cellular measurements 
indicate that α-Syn disrupts the upstream trafficking stages including vesicle tethering or 
vesicle re-clustering as well, resulting in dispersion of vesicles away from the fusion 
active zone [123, 134].  ere, we speculate that high concentration of α-Syn may form 
into oligomer when binding to membrane surface and the inhibitory effect in vesicle 
docking by α-Syn might be caused by its oligomer either blocking the available surface 
of acidic phospholipids in the membrane from opposing membrane to interact, or 
clustering vesicles to reduce the available vesicle pool. Thus, α-Syn, like other regulatory 
protein such as complexin and Munc-18 [137, 138], might have dual functions: inhibiting 
membrane fusion through phospholipid binding and stimulating SNARE complex 
assembly via binding to VAMP2. 
In conclusion, our results demonstrate that α-Syn has the capacity of inhibiting 
SNARE-dependent vesicle docking, most likely via membrane binding, whereby 
attenuating release of neurotransmitters at the synapse. 
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Methods 
Plasmid Constructs and Site-Directed Mutagenesis.  
DNA sequences encoding syntaxin 1A (amino acids 1-288 with three cysteines 
replaced by alanines), VAMP2 (amino acids 1–116 with C103 replaced by alanines), 
SNAP-25 (amino acids 1-206 with four native cysteines replaced by alanines), SNAP-25 
BoNT/E ( amino acids 1-180), soluble VAMP2 (amino acids 1-96), α-synuclein (amino 
acids 1-140), Sso1p HT (amino acids 185-290), for which the N-terminal α-helix Habc 
domain was deleted, and Snc2p (amino acid 1-115) were inserted into the pGEX-KG 
vector as N-terminal glutathione S-transferase (GST) fusion proteins. While Sec9c 
(amino acid 401-651 of Sce9) was insert into the PET-28b vector as C-terminal His6-
tagged fusion protein. We used the Quick Change site-directed mutagenesis kit 
(Stratagene) to generate all cysteine mutants, including SyxF I187C, SyxF G288C, 
V  P   1  , V  P  T116 , α-Syn    P, α-Syn  46K, and α-Syn A53T; DNA 
sequences were confirmed by the Iowa State University DNA Sequencing Facility. 
Protein expression, purification and labeling.  
 ll cysteine mutant recombinant neuronal and yeast S     proteins, and α-Syn 
were expressed as N-terminal glutathione-S-transferase fusion proteins. Recombinant 
proteins were expressed in Escherichia coli Rosetta (DE3) pLysS (Novagene). The cells 
were grown at  7 °  in    medium with 1   μg ml-1 ampicillin until the absorbance at 
600 nm reached 0.6–0.8. The cells were further grown for overnight after adding IPTG 
(0.5 mM final concentration) at 16 °C.  
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His6-tagged Sec9c was purified using the Ni-NTA agarose beads (QIAGEN). The 
beads were washed with washing buffer (HEPES buffer with 20 mM immidazole [pH 
7.4]), and then the protein was eluted out by elution buffer (HEPES buffer with 150 mM 
immidazole [pH 7.4]). We purified other SNARE proteins and cysteine mutants using 
glutathione-agarose chromatography. Cell pellets were resuspended in 20 ml PBS, pH 7.4, 
containing 0.2% (v/v) Triton X-100, with final concentration of 1 mM 4-(2-aminoethyl)-
benzenesulfonyl fluoride (AEBSF), 2 mM DTT. Cells were broken by sonication in an 
ice bath and centrifuged at 15,000 rpm for 30 min at 4 °C. The supernatant was mixed 
with 2 ml glutathione-agarose beads in PBS and nutated in the cold room (4 °C) for 2 h. 
The proteins were then cleaved by thrombin in cleavage buffer (50 mM Tris HCl, 150 
mM NaCl, pH 8.0) with 0.8 g per 100 ml n-octyl-D-glucopyranoside (OG) for all the 
neuronal and yeast SNARE proteins except Sec9c, and all the cysteine mutants, or 
cleaved by thrombin in cleavage buffer for soluble VAMP2, wild-type α-Syn and α-Syn 
mutants. Purified proteins were examined with 15% SDS-PAGE, and the purity was at 
least 85% for all proteins.    
SyxF and VAMP2 cysteine mutants were labeled with the fluorescence labels 
Cy3 and Cy5 maleimide (Amersham). The reaction mixture, with the dye to protein ratio 
of more than 5:1, was left overnight at 4°C. The free dye was removed using the PD-10 
desalting column (Amersham). All labeled proteins were analyzed by the SDS-
polyacryamide gel in which the labeled proteins ran a little slower than the wild-type, and 
the labeling efficiency was over 80% for all proteins. 
Membrane reconstitution.  
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The mixture of POPC (1-palmitoyl-2-dioleoyl-sn-glycero-3-phosphatidylcholine), 
DOPS (1,2-dioleoyl-sn-glycero-3-phosphatidylserine), Cholesterol and DiI (t-vesicles) or 
DiD (v-vesicles) (molar ratio of 43:15:40:2) in chloroform was dried in a vacuum and 
was resuspended in a buffer (25 mM HEPES/KOH and 100 mM KCl [pH 7.4]) to make 
the total lipid concentration of about 10 mM. Protein-free large unilamellar vesicles 
(~100 nm in diameter) were prepared by extrusion through polycarbonate filters (Avanti 
Polar Lipids). For net neutral charge lipid mixing, 15 mol% DOPS was replaced by 
equimolar quantity of POPC. For the NN-FRET and CC-FRET assay, the vesicles 
contained 2 mol% more POPC in replacement of equimolar DiI or DiD, and the total 
lipid concentration is 25 mM.   
SyxF or labeled SyxF and SNAP-25, in a molar ratio of 1:1.5, were premixed, and 
the mixture was left at room temperature for 1 hour to form the complex before the 
reconstitution. For yeast lipid mixing assay, Sso1p alone was reconstituted into 
membrane without pre-forming into binary complex with Sec9c. For membrane 
reconstitution, proteins were mixed with vesicles at the protein to lipid molar ratio of 
1:200 with ~0.8 g per 100 ml OG in the buffer at 4°C for 15 min. The mixture was 
diluted two times with dialysis buffer (25 mM HEPES, 100 mM KCl, pH 7.4), and this 
diluted mixture was then dialyzed in 2 L dialysis buffer at 4°C for overnight. 
Lipid mixing assay.  
For neuronal SNARE dependent lipid mixing, reconstituted t-vesicle and v-
vesicle were mixed at a ratio of 1:1. The total lipid concentration in the reaction is 0.1 
mM. The fluorescence intensity was monitored in two channels with the excitation 
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wavelength of 530 nm and emission wavelengths of 570 and 670 nm for DiI and DiD dye 
pairs, respectively. Fluorescence changes were recorded with the same Varian fluorimeter. 
All measurements were performed at 35°C. For yeast lipid mixing assay, lipid 
concentration is the same as neuronal SNARE-induced lipid mixing, and the FRET 
reaction started when 1 μ  Sec9c was mixed with t- and v- liposomes. The initial rate 
was calculated by analyzing the slope value within the beginning 150 sec. And the initial 
rate of control group was normalized to 1. 
FRET assays.  
Reconstituted t-and v-vesicles were mixed at a ratio of 1:1. The fluorescence 
intensity was monitored in two channels with the excitation wavelength of 545 nm and 
emission wavelengths of 570 and 668 nm for Amersham Cy Dye, respectively. 
Fluorescence changes were recorded with the Varian Cary Eclipse model fluorescence 
spectrophotometer using a quartz cell of 100 μ  with a   mm path length.  ll 
measurements were performed at 35°C. The initial rate was calculated by analyzing the 
slope value within the beginning 150 sec. And the initial rate of control group was 
normalized to 1. 
Single vesicle lipid mixing assay.  
Details of the single-vesicle fusion FRET assay have been described earlier (Ying 
et al. 2013). A quartz slide was cleaned using the 5% Alexon solution followed by 1 M 
potassium hydroxide, and then coated with 99:1 (mol/mol) mPEG:biotin-PEG (Laysan 
Bio). This PEG-treated quartz slide was placed as the bottom surface of a microfluidic 
chamber to be used as the imaging surface of our prism-type total internal reflection 
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fluorescence (TIRF) microscopy (based on IX-71, Olympus). To monitor interactions 
between single v- and t-vesicles, the v-vesicles (30 µM [lipids]) were attached on this 
quartz imaging surface via neutravidin (Invitrogen) that acts as molecular glue between 
biotin-PEG and biotinylated lipids. The t-vesicles (10 µM [lipids]) and the Ca2+ ion 
solution were mixed together just prior to the main reaction. We used only deionized 
water to make the Ca2+ ion solutions, which seemed to minimize errors in obtaining the 
prescribed Ca2+ concentration. This t-vesicle-Ca2+ mixture was introduced into the flow 
chamber for the fusion reaction, and the temperature was maintained at 37 °C during the 
reaction.  
In the docking-number analysis, we used a computer algorithm that detects local 
Gaussian maxima in the TIRF images that were recorded by an electron-multiplying 
charge-coupled device (iXon DU897v, Andor technology) to count the number of the 
single-vesicle complexes in a given area (programs available at 
http://bio.physics.illinois.edu/). Our TIRF microscopy monitored the imaging area of 
45x90 µm
2
 at a time, and we calculated the ratio of docked t-vesicles and total anchored 
v-vesicles as docking probability. Therefore, it could be directly compared for different 
molecular conditions. Using the same algorithm as used for the docking-number analysis, 
each vesicle-vesicle docking event and the subsequent fusion process were individually 
identified. We quantified the FRET efficiency using the equation, IA/(ID+ IA) where ID 
and IA are the donor and acceptor fluorescence intensities respectively. Fusion 
percentage was calculated by the percentage of fusion events with FRET efficiency 
higher than 0.5.   
Single vesicle content mixing 
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For the real-time imaging of small sulforhodamine B content release, the same 
PEG surface was used as above. After the surface was coated with neutravidin, the 
sulforhodamine B containing v-SNARE vesicles were immobilized on the PEG-coated 
surface. After two rounds of 1 ml buffer wash, empty t-SNARE vesicles were injected 
into the channel incubating with v-SNARE vesicles. After 30 minutes incubation in room 
temperature (     ),         a + was in ected at a speed of     l/sec by a motorized 
syringe pump. 
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Figures and Legends 
 
Figure1. α-Syn inhibits SNARE-induced lipid mixing. (A) The change of fluorescence intensity of DiD 
reflects lipid mixing. The red trace is the control with t-liposome reconstituted with SyxF/SNAP-25 
and v-liposome reconstituted with VAMP2. The yellow trace represents the lipid mixing for 5 M α-
Syn, the green trace for 10 M α-Syn, the blue trace for 25 M α-Syn and the pink trace for 50 M α-
Syn. The dark red trace is the lipid mixing control with 10 μM soluble VAMP2 (Vps). (B) 
Normalized initial rates of the lipid mixing assays at different α-Syn concentrations. Error bars, 
which represent the standard deviations, were obtained from 3 independent measurements with 3 
different preparations. 
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Figure2. Lipid binding affinity of α-Syn correlates to the inhibition effect of membrane fusion. The 
change of fluorescence intensity of DiD reflects lipid mixing. The red traces are lipid mixing control 
group. The green traces represent the lipid mixing with α-Syn, while the blue, cyan, and pink traces 
represent the lipid mixing with α-Syn A30P (A), α-Syn E46K (C) and α-Syn A53T (E) at the 
concentration of 10 μM, 25 μM and 50 μM, respectively. The black trace is the lipid mixing control 
with 10 μM Vps. Normalized initial rates of the lipid mixing assays at different α-Syn and α-Syn 
A30P (B), α-Syn E46K (D) and α-Syn A53T (F) concentrations. Error bars, which represent the 
standard deviations, were obtained from 3 independent measurements with 3 different preparations. 
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Figure3. α-Syn promotes SNARE-induced neutral lipid mixing. (A) The change of fluorescence 
intensity of DiD reflects neutral lipid mixing. The red trace is the control with t-liposome 
reconstituted with SyxF/SNAP-25 and v-liposome reconstituted with VAMP2. The green trace 
represents the lipid mixing for 10 M α-Syn, the blue trace for 25 M α-Syn, and the pink trace for 
50 M α-Syn. The black trace is the lipid mixing control with 10 M soluble VAMP2 (Vps). (B) 
Normalized initial rates of the lipid mixing assays at different α-Syn concentrations. Error bars, 
which represent the standard deviations, were obtained from 3 independent measurements with 3 
different preparations. 
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Figure4. α-Syn inhibits lipid fusion mediated by yeast SNREs. (A) The change of fluorescence 
intensity of DiD reflects lipid mixing. The black trace is the control with t-liposome reconstituted 
with Sso1P and v-liposome reconstituted with Snc2P. The yellow trace represents the lipid mixing for 
5 M α-Syn, the green trace for 10 M α-Syn, the blue trace for 25 M α-Syn and the pink trace for 
50 M α-Syn. (B) Normalized initial rates of the lipid mixing assays at different α-Syn concentrations. 
Error bars, which represent the standard deviations, were obtained from 3 independent 
measurements with 3 different preparations. 
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Figure5. The effect of α-Syn on vesicle docking and content release (A) Bar graph of vesicle  
docking probability with or without α-syn. (B) Bar graph of lipid mixing fraction with or without α-
Syn. (C) α-Syn does not affect single vesicle content mixing in the presence of Syt1 and Ca2+. (D), (E) 
Docking probability and content release of α-Syn mutants compared to α-Syn wild type. (F) Real 
time docking events with or without α-Syn wild type or mutants. 
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Figure6. α-Syn contains oligomers (A) Western blot of α-Syn shows monomer, dimer, trimer, 
tetramer, pentamer from bottom to top (B) Monomeric form of α-Syn was separated using FPLC. (C) 
10uM of α-Syn monomer inhibits ensemble SNARE-mediated membrane fusion. 
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CHAPTER 5: GENERAL CONCLUSION 
 
The effects of cholesterol and α-Synuclein on SNARE-mediated fusion were 
examined throughout this dissertation.  
Using yeast trafficking SNAREs on dissected-ensemble liposome assay, where 
the FRET between N-terminal of two SNAREs, lipid mixing of two vesicles from both 
outer and inner, and C-terminal of two membranes of opposing SNAREs were measured. 
Cholesterol content was 40mol%, a physiological concentration in synaptic vesicles. 
When comparing t- and v-vesicles containing cholesterol 40mol% to those without 
cholesterol, the NN-FRET assay showed that cholesterol enhanced SNARE assembly by 
6 times in second order reaction rate. Outer leaflet mixing was dramatically increased by 
as much as 30 times while inner leaflet mixing was enhanced by 12 times. As a pore 
expansion marker for this constitutive fusion mediated by yeast SANREs, FRET between 
the C-terminal of sso1 and that of snc2p was enhanced by cholesterol by as much as 3 
times by cholesterol. Cholesterol was a strong stimulator for hemifusion, but for 
subsequent fusion pore formation and pore expansion it was a mild stimulator at 40 
mole%. 
The neuronal SNAREs on single vesicular study also revealed that cholesterol 
enhanced docking, lipid mixing and both Ca
2+
-independent and Ca
2+
-dependent content 
release. When comparing t- and v-vesicle containing 40mol% cholesterol to those 
without cholesterol, the extent of docking was twice enhanced and lipid mixing was 
enhanced slightly. Cholesterol enhanced Ca
2+
-independent content release by 40 times. 
For triggered fusion, a 50% increase was detected. Interestingly, these enhancements 
100 
 
occurred when t- and v-vesicle both have cholesterol. Syntaxins was assembled into 
higher clusters as the amount of cholesterol increased while Vamp produced no change in 
the assembly. Furthermore, cholesterol reduced the fusion delay time. Overall, 
cholesterol was needed at both sides to have effective role in vesicle fusion.  
α-Syn inhibited ensemble lipid mixing both in neuronal SNARE and yeast 
SNARE-mediated membrane fusion. Also, mutants linked to familial PD A30P, A53T, 
and E46K, which are less effective than, similar to or more than the wild-type in fusion-
inhibition, respectively, correlating well with the rank order of their individual membrane 
affinities. When the liposomes didn’t contain a negatively- charged lipid DOPS, in which 
α-Syn binds, the inhibition disappeared. Furthermore single vesicular experiments found 
that α-Syn specifically inhibits vesicle docking, without interfering with lipid mixing and 
pore opening. Thus, α-Syn may inhibit SNARE-dependent vesicle docking through 
membrane binding. 
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